Literature DB >> 1711440

Prophylaxis for genital herpes. Should it be used routinely?

A Mindel1.   

Abstract

Mesh：

Substances：

Year:  1991        PMID： 1711440     DOI： 10.2165/00003495-199141030-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  59 in total

Review 1.  Herpes simplex infections in hematologic malignancies.

Authors:  S A Muller; E C Herrmann; R K Winkelmann
Journal:  Am J Med       Date:  1972-01       Impact factor: 4.965

2.  Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial.

Authors:  R C Reichman; G J Badger; G J Mertz; L Corey; D D Richman; J D Connor; D Redfield; M C Savoia; M N Oxman; Y Bryson
Journal:  JAMA       Date:  1984-04-27       Impact factor: 56.272

3.  Intravenous acyclovir for the treatment of primary genital herpes.

Authors:  L Corey; K H Fife; J K Benedetti; C A Winter; A Fahnlander; J D Connor; M A Hintz; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

4.  Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.

Authors:  G J Mertz; L Eron; R Kaufman; L Goldberg; B Raab; M Conant; J Mills; T Kurtz; L G Davis
Journal:  Am J Med       Date:  1988-08-29       Impact factor: 4.965

5.  Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment.

Authors:  S E Straus; K D Croen; M H Sawyer; A G Freifeld; J M Felser; J K Dale; H A Smith; C Hallahan; S N Lehrman
Journal:  JAMA       Date:  1988-10-21       Impact factor: 56.272

6.  Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation.

Authors:  J C Wade; B Newton; N Flournoy; J D Meyers
Journal:  Ann Intern Med       Date:  1984-06       Impact factor: 25.391

7.  Pathogenicity in mice of strains of herpes simplex virus which are resistant to acyclovir in vitro and in vivo.

Authors:  H J Field; G Darby
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

8.  Recognition and quantitation of herpesvirus particles in human vesicular lesions.

Authors:  K O SMITH; J L MELNICK
Journal:  Science       Date:  1962-08-17       Impact factor: 47.728

9.  Acyclovir prophylaxis of herpes-simplex-virus infections.

Authors:  R Saral; W H Burns; O L Laskin; G W Santos; P S Lietman
Journal:  N Engl J Med       Date:  1981-07-09       Impact factor: 91.245

Review 10.  Acyclovir. An updated review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  J J O'Brien; D M Campoli-Richards
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.